drugset / Trial / NCT03266419

Effectiveness of Deep Versus Moderate Neuromuscular Blockade

NCT03266419 ↗

Completed 100 enrolled Asan Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to evaluate the influence of depth of neuromuscular blockade during laparoscopic gastrectomy on postoperative pain in surgical patients allocated randomly to either deep or moderate neuromuscular blockade group with standard-pressure pneumoperitoneum of 13 mmHg.

Timeline

Start
2018-03-28
Primary completion
2018-11-01
Completion
2018-11-02

Outcome

Missed primary endpoint

paper Deep, compared with moderate, NMB did not significantly reduce the MEAD of oxycodone administered in the PACU. PMID 31503037 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified 0.2 mg/kg Intravenous
Subject Rocuronium Other / unclassified 0.6 mg/kg Intravenous
Subject Rocuronium Other / unclassified 0.8 mg/kg Intravenous
Subject Rocuronium Other / unclassified 1.2 mg/kg Intravenous

Indications

No indication recorded.